Maryland Capital Advisors’s Exelixis EXEL Stock Holding History

Maryland Capital Advisors’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$164	Buy	+3	New	+$146	﹤0.01%	508

Other funds holding EXEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Maryland Capital Advisors's EXEL Position: Q2 2026 in Review

Maryland Capital Advisors opened a new position in Exelixis (EXEL) in Q2 2026: 3 shares worth $164. The stake represents ﹤0.01% of the portfolio and ranks #508 among its holdings.

756 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

Maryland Capital Advisors held 3 shares of Exelixis worth $164 as of Q2 2026.
Exelixis was a new Maryland Capital Advisors position in Q2 2026.
Exelixis made up ﹤0.01% of Maryland Capital Advisors's portfolio in Q2 2026, its #508 holding.
756 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Maryland Capital Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.